Gore will take ownership of InnAVasc’s arteriovenous graft, the report said. InnAVasc CEO Joseph Knight, PhD, told WRAL that the company sees “an array of synergies working with Gore.”
Financial terms were not disclosed.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
